Signal de tendance

Évolution des mentions ✨ Nouveau
30j7jMaintenant

4

mentions (7j)

4

mentions (30j)

17 avr. 2026

premier signal

1

pays concernés

Contexte et analyse

Cette tendance "Long-term study links common IBS medications to higher mortality" a été détectée dans la catégorie Santé & Médecine avec un score de 100/100. Cette tendance connaît une croissance explosive et attire beaucoup d'attention actuellement.

Entités liées

https://www.sciencedaily.com/releases/2026/04/260415043617.htmhttps://www.news-medical.net/news/20260413/Higher-mortality-risk-in-IBS-patients-using-antidepressants.aspxhttps://www.healthline.com/health-news/common-ibs-treatments-higher-risk-early-deathhttps://www.msn.com/en-xl/news/other/common-treatments-for-irritable-bowel-syndrome-linked-to-higher-risk-of-death-study-warns/ar-AA20rEk1?cvid=69ddad5fe1e2459b97fe5f0a53c6569d&ocid=wispr

Extraits des sources

Science News from research organizations * * * Date:April 16, 2026 Source:Cedars-Sinai Medical Center Summary:A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some widely used medications—including antidepressants and certain antidiarrheal drugs—were linked to a small but noticeable increase in the risk of death over time.Share: FULL STORY * * * ! A large...

— sciencedaily.com

Ce que disent les sources

  • "A nearly 20-year study of over 650,000 Americans with IBS found associations between certain antidepressants and antidiarrheal drugs and a small but increased risk of death."

  • "Research indicates that antidepressant use in IBS is linked to a 35% higher risk of all-cause mortality, highlighting safety issues with long-term..."

  • "Researchers say some medications prescribed for irritable bowel syndrome (IBS) may increase a person's risk of early death. However, the risk is relatively..."

  • "Several of the most common treatments for irritable bowel syndrome could raise the risk of death, a study from researchers at Cedars-Sinai Health Sciences..."

Partager cette tendance

X LinkedIn